BCG Biosensor and Non- and Invasive Monitoring During Emergency Medicine Cases, a Prospective Feasibility Study

Summary

In a out of hospital emergency medicine study the investigators will measure hemodynamic effects of implemented treatments for patients with cardiac arrest, hypotension, and intensive care transports. The investigators will use both non-invasive and invasive measuring technology to measure this. Ballistocardiographic biosensors are introduced together with more advanced non-invasive and invasive measurements such as invasive arterial blood pressure with cardiac output calculation and saturation cerebral tissue oxygenation (SctO2). During treatment of cardiac arrest patients the investigators will use a new LUCAS 2 Active Decompression device (LUCAS 2 AD2) and measure different hemodynamic variables.

Conditions

• Cardiac Arrest, Out-Of-Hospital
• Hypotension and Shock

Interventions

DEVICE

LUCAS 2 Active Decompression 2

Chest compression with active decompression of the chest. Measurement of physiological parameters.

OTHER

Hypotension

measurement of physiological parameters

OTHER

Intensive care transport

Measurement of physiological parameters

Sponsors & Collaborators

• Norwegian Telemedicine

  collaborator UNKNOWN

• Kopera Norway

  collaborator UNKNOWN

• Edwards Medical

  collaborator UNKNOWN

• Stryker Medical

  collaborator INDUSTRY

• University of Bilbao

  collaborator UNKNOWN

• University of Stavanger

  collaborator OTHER

• Oslo University Hospital

  lead OTHER

Principal Investigators

• Lars Wik, MD, PhD · Oslo University Hospital

Study Design

Allocation

NON_RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Model

PARALLEL

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2021-05-18

Primary Completion

2024-01-03

Completion

2024-01-03

Countries

• Norway

Study Locations